Information about Lasik eye surgery, a new technique to treat cataracts

NewsGuard 100/100 Score

Cataracts cause vision problems in over half of all Americans, age 65 and older. For those between 55 and 65 years of age, cataracts are a leading cause of vision loss.

Using an advanced microsurgical technology, called Aqualase(R), a New York eye surgeon is now able to use a procedure to essentially "wash" cataracts away. "By using Aqualase(R) to treat my cataract patients, I am able to dissolve the clouded lens with pulses of warm, naturally balanced salt water solution in order to 'wash away' the lens layer by layer," said Satish Modi, M.D., F.R.C.S. ( C ), a leading ophthalmic surgeon in Poughkeepsie.

Aqualase(R) uses fluid micropulses to gently delaminate and emulsify cloudy lens tissue without mechanical or thermal disruption of surrounding tissue. This technology may help reduce the risk of complications from the most common cataract removal procedure, called phacoemulsification. "Phacoemulsification is a very safe and effective cataract removal technique.

It does heat the eye somewhat, which can rarely prevent the eye from healing properly or as quickly as we would like. Because Aqualase(R) doesn't heat the eye, the potential for these complications is further minimized," said Dr. Modi. A limited number of eye surgery centers throughout the U.S. have been selected to use Aqualase(R) technology. In the future, it is believed that Aqualase(R) technology will be applied to a number of other eye surgery procedures to further enhance their safety and effectiveness. To learn more, contact Stacey Koch at 1-877-MODI-EYE or [email protected].

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema